Science Current Events | Science News | Brightsurf.com
 
Email a Friend Send to a friend
Printer Friendly Print Research shows cord blood comparable to matched bone marrow

Research shows cord blood comparable to matched bone marrow

June 08, 2007

Lancet study suggests need to increase inventory of cord blood

University of Minnesota researchers report that umbilical cord blood transplants may offer blood cancer patients better outcomes than bone marrow transplants, according to an analysis of outcome data performed at the Center for International Blood and Marrow Transplant Research (CIBMTR), Medical College of Wisconsin, Milwaukee.




This is the first study that directly compares matched bone marrow, which is currently considered the preferred graft, with matched and mismatched umbilical cord blood. There is considerable controversy in the medical community about which source of blood stem cells (cord blood or marrow) should be considered the "gold standard" for treatment of childhood leukemia.

In this study, the investigators compared outcomes of pediatric leukemia patients who received unrelated bone marrow transplants with those who received umbilical cord transplants. While all bone marrow donors were matched, nearly all cord blood donors were mismatched.

The main objective of the research was to compare the results after cord blood and marrow transplantation and provide guidelines to transplant physicians on the selection of the best donor for children with leukemia. Remarkably, mismatched cord blood performed as well as matched bone marrow as measured by leukemia-free survival rates, providing the degree of mismatch was limited and the number of cord blood cells available was sufficient. Furthermore, study participants who received matched cord blood had a 20 percent higher survival rate than matched bone marrow recipients, though the number of matched cord blood transplants was small.

The research appears in the June 9, 2007, issue of The Lancet with John E. Wagner, M.D., professor of Pediatrics and director of the University of Minnesota Medical School's division of Pediatric Hematology/Oncology and Bone Marrow Transplantation, as senior investigator.

The study was done in collaboration with the National Cord Blood Program of the New York Blood Center, New York. Mary Eapen, M.D., associate professor of Pediatrics at the Medical College of Wisconsin and Associate Scientific Director of the CIBMTR, is the first author.

"What this study suggests is that cord blood need not be considered a second line therapy any longer. The fact that cord blood is banked and readily available with little notice is a great advantage. Today, leukemia patients can wait months for an appropriately matched bone marrow donor, during which time their disease might return," Wagner said. "For the first time, the timing of transplantation can be dictated by the patient's needs as opposed to the availability of the matched bone marrow."

The research suggests that it will become more important to invest in cord blood banks that meet certain standards in relation to cell dose (or volume of the transplanted cells) and Human Leukocyte Antigen (HLA) diversity.

Human Leukocyte Antigens (HLA) are a group of proteins on bone marrow cells that can provoke the immune system to respond. When doing bone marrow or cord blood transplants, doctors generally try to have the donors' and recipients' HLA types match as closely as possible.

Wagner added that increasing the inventory will increase the chance of finding donors for ethnic and racial minorities currently underrepresented in volunteer marrow registries worldwide.

While the study showed that umbilical cord blood took longer to rebuild the blood-making cells in the body, it was associated with a lower risk of graft versus host disease, a potentially lethal complication, especially when HLA types are mismatched. Rates of leukemia relapse also are lower with mismatched umbilical cord blood transplants. This study also showed that in addition to having a good match, higher cell doses for umbilical cord blood transplants improved survival rates.

The study was done by extensive review of clinical data from transplant centers around the country and reported to the CIBMTR at the Medical College of Wisconsin, Milwaukee and the National Cord Blood Program at the New York Blood Center. The analysis included transplant outcomes in 785 children younger than 16 who had the diagnosis of acute lymphoblastic leukemia (ALL) or acute myeloid leukemia (AML).

University of Minnesota



Related Cord Blood Current Events and Cord Blood News Articles Cord Blood Current Events and Cord Blood News RSS Cord Blood Current Events and Cord Blood News RSS
U of M researchers find 2 units of umbilical cord blood reduce risk of leukemia recurrence
A new study from the Masonic Cancer Center, University of Minnesota shows that patients who have acute leukemia and are transplanted with two units of umbilical cord blood (UCB) have significantly reduced risk of the disease returning.

The use of stem cells in regenerative medicine may also be detrimental for health
The use of stem cells in regenerative medicine is not always beneficial for human health, it may even be harmful according to a work done by the University of Granada and University of León. Scientists have demonstrated that transplantation of human mononuclear cells isolated from umbilical cord blood exerted a deleterious effect in rats with liver cirrhosis.

NIH launches 2009 H1N1 influenza vaccine trials in HIV-infected pregnant women
The first clinical trials to test whether the 2009 H1N1 influenza vaccine can safely elicit a protective immune response in pregnant women launched yesterday, and a trial to conduct the same test in HIV-infected children and youth will begin next week.

Private umbilical cord banking not cost-effective, UCSF research shows
Private cord blood banking is not cost-effective because it costs an additional $1,374,246 per life-year gained, according to a new analysis by UCSF researchers.

Case Western Reserve researchers discover the key to malaria susceptibility in children
A team of researchers from Case Western Reserve University School of Medicine have solved the mystery of why some children are more susceptible to malaria infection and anemia.

Human term placenta a new abundant source of hematopoietic cells
Investigators at Children's Hospital Oakland Research Institute, Oakland, California found a way to obtain large numbers of hematopoietic stem cell from human term placenta.

Exposure to phthalates may be a risk factor for low birth weight in infants
Many parents worry about their child's exposure to phthalates, the chemical compounds used as plasticizers in a wide variety of personal care products, children's toys, and medical devices.

Children susceptible to pesticides longer than expected, study finds
Although it is known that infants are more susceptible than adults to the toxic effects of pesticides, this increased vulnerability may extend much longer into childhood than expected.

Children's Hospital Oakland scientists first to discover new source for harvesting stem cells
A groundbreaking study conducted by Children's Hospital & Research Center Oakland is the first to reveal a new avenue for harvesting stem cells from a woman's placenta, or more specifically the discarded placentas of healthy newborns.

Embryo's heartbeat drives blood stem cell formation
Biologists have long wondered why the embryonic heart begins beating so early, before the tissues actually need to be infused with blood.
More Cord Blood Current Events and Cord Blood News Articles
Umbilical Cord Stem Cell Therapy: The Gift of Healing from Healthy Newborns

Umbilical Cord Stem Cell Therapy: The Gift of Healing from Healthy Newborns
by Anthony G. Payne (Author), David Steenblock (Author)

We are standing at the threshold of a new and exciting medical era-an era of regeneration, rejuvenation, and renewal in which stems cells will set the stage for healing and in some cases, the restoration of injured, diseased, and debilitated tissues and organ. While stem cell therapy is still in its infancy, the field is rich with promise. The debate over the use of embryonic stem cells and the questionable effectiveness of adult stem cells have led many scientists and clinicians to concentrate their energies on umbilical-cord-derived stem cells from healthy newborn babies. While these cells are technically classifed as "adult stem cells," they appear to have greater restorative and regenerative potential than stem cells derived from adult tissues due to their young age. Human...

ABC News Nightline Your Child's Umbilical Cord

ABC News Nightline Your Child's Umbilical Cord

If you could derive medical benefits by harvesting the blood from a freshly discarded umbilical cord, it's hard to think of any ethical reason why you shouldn't do so. As it is, about 3.5 million umbilical chords are thrown into the trash every year. Since that cord blood, as it's known, is rich in blood-forming stem cells, which can then be used in transplantation instead of bone marrow, saving it, storing it would seem to make eminently good sense. Indeed, there are already several thriving businesses that have grown up around that very premise. For a couple of thousand dollars or so, the companies will collect the blood from your baby's umbilical cord. And for about $100 a year, they'll store it in a refrigerated container. Then, should the baby or any immediate member of the...

Rambo First Blood Green Cord Wrapped Num. Sign. Edition

Rambo First Blood Green Cord Wrapped Num. Sign. Edition
by Master Cutlery

ATTRIBUTES Blade Detail: Plain Edge Blade Length (inches): 9.00 Blade Material: Stainless Carry System: Leather Sheath Handle Material: Cord Wrapped Overall Length (inches): 14.00 Special Features: Numbered and Signature Survival Kit in Handle

Microlife AD-120 AC Adapter

Microlife AD-120 AC Adapter
by Microlife

The Microlife AC Adapter Model #AD-120 is a convenient alternative to batteries for Microlife brand automatic and semi-automatic blood pressure monitors. It fits standard electrical outlets and features a convenient long cord. Input: 120VAC 60HZ 15V, Output: 6VDC 600MA. Not compatible with Microlife Model #3MQ1 (use AC Adapter AD-1024A).

  Thermo Scientific CryoMed CryoPlus and Cryo Series Racks and Holders;10 Place Cord Blood Rack
by Thermo Scientific

Cord Blood Freezer Rack;Thermo Scientific; CryoMed; 10-place; For use with all CryoMed Freezer Models

coupon for cord blood registery during pregnancy value $250 Discount Code# MMEDS

coupon for cord blood registery during pregnancy value $250 Discount Code# MMEDS
by CBR, Cord Blood Registery

A SPECIAL GIFT FOR YOU FROM A CBR MOM ALL YOU HAVE TO DO IS GO TO CORDBLOOD.COM THE OFFICIAL CBR WEBSITE ENTER THIS CODE: MMEDS WHEN YOU REGISTER OR CALL 1-888-CORD BLOOD AND GIVE THEM THIS DISCOUNT CODE: MMEDS AND THEY WILL GIVE YOU THE DISCOUNT DIRECTLY AND SEND YOU THE KIT WITH ALL THE INFORMATION THAT YOU WILL NEED. IF YOU DO WANT TO CONTACT ME DIRECTLY PLEASE PLACE YOUR BID AND I CAN SEND YOU ALL THE INFORMATION AND HANDLE YOUR REGISTRATION WITH CBR PERSONALLY WITH NO ADDITIONAL COST PLEASE REMEMBER YOU MUST TAKE THAT KIT WITH YOU TO THE HOSPITAL AT THE TIME OF DELIVERY AND YOU MUST INFORM YOUR DOCTOR IN ADVANCE OF YOUR DECISION TO STORE YOUR CHILDS CORD BLOOD THIS IS A ONCE IN A LIFETIME OPPORTUNITY PLEASE DONT LET IT PASS YOU BY! I HAVE MANY FRIENDS WHO REGRET...

John Rambo: First Blood Signature Edition Knife Replica

John Rambo: First Blood Signature Edition Knife Replica
by Hollywood Collectibles

Hollywood Collectibles has recreated Rambo's historic knives from the film trilogy that began with First Blood, continued in Rambo: First Blood Part II, and concluded in Rambo III! The First Blood Signature Edition knife measures 14" in overall length and features a top-quality 420 stainless steel blade with slotted saw teeth, a hollow handle with survival kit, aluminum butt cap with precision compass, and a double screwdriver guard. The Rambo: First Blood Part II Signature Edition knife features a matte finish stainless steel blade, center slotted saw teeth, Phillips and standard screwdriver points, stainless guard with lashing holes, hollow handle wrapped in heavy nylon cord with waterproof O-Rings and survival kits and non-magnetic aluminum butt-cap with precision compass. Offered for...

Cord Blood

Cord Blood
Aaron Martin (Primary Contributor)



Frontiers of Cord Blood Science

Frontiers of Cord Blood Science
by Niranjan Bhattacharya (Editor), Phillip Stubblefield (Editor)

Cord blood is a significant source of hematopoietic stem and progenitor cells for the treatment of blood and genetic disorders. Cord blood is also an alternative to embryos as a source of tissue for regenerative medicine. Cells from cord blood have been shown to transdifferentiate into nonhematopoietic cells, including those of the brain, heart, liver, pancreas, bone, and cartilage, in tissue culture and in animal systems. Recently it has been demonstrated that both cardiac and glial cell differentiation of cord blood donor cells occurred in recipients of unrelated donor cord blood transplantation as part of a treatment regime for Krabbe disease and Sanfilippo syndrome. These observations raise the possibility that cord blood may serve as a source of cells to facilitate tissue repair...

  Discover the Power of Stem Cells
Also With: various (Primary Contributor)



© 2009 BrightSurf.com